Portfolio company
Tolergyx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Aravax
This clinical-stage pharmaceutical company develops peptide immunotherapies for patients with food allergies, including a lead product for peanut allergy.
Moonlight Therapeutics
This biotechnology company develops microneedle dermal stamps that deliver allergen immunotherapy to patients suffering from peanut and other food allergies.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
Toleranzia
This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.
Poplar Therapeutics
The company develops anti-immunoglobulin E antibody therapies to treat patients with food allergies and other atopic conditions.
Dualyx
This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.
Desentum
This biopharmaceutical company develops allergen immunotherapy products to treat patients suffering from respiratory and food allergies.
